Molecular Basis of Anthracycline-Induced Cardiotoxicity and Its Prevention
- 1 September 2000
- journal article
- review article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 71 (1-2) , 436-444
- https://doi.org/10.1006/mgme.2000.3043
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Anthracyclines Enhance Tension Development in Cardiac Muscle by Direct Interaction with the Contractile SystemJournal of Molecular and Cellular Cardiology, 1997
- Analyses of the Molecular Mechanism of Adriamycin-Induced CardiotoxicityFree Radical Biology & Medicine, 1997
- Editorial: ICRF-187 As a Cardioprotectant in Children Treated with AnthracyclinesPediatric Hematology and Oncology, 1997
- The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice.Journal of Clinical Investigation, 1996
- Protective Effect of Butylated Hydroxyanisole on Adriamycin-induced CardiotoxicityJournal of Pharmacy and Pharmacology, 1996
- Suppression of Doxorubicin Cardiotoxicity by Overexpression of Catalase in the Heart of Transgenic MiceJournal of Biological Chemistry, 1996
- Polymorphism in Detoxifying Enzymes and Susceptibility to Skin CancerPhotochemistry and Photobiology, 1996
- Cardioprotection of rat heart myocytes with amifostine (Ethyol®) and its free thiol, WR-1065, in vitroEuropean Journal Of Cancer, 1996
- Clinical and morphologic cardiac findings after anthracycline chemotherapyThe American Journal of Cardiology, 1983